CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Loxam Teri Director | Grant or award | +2,265 | 12,481 | ||
| 2026-06-15 | Loxam Teri Director | Grant or award · Stock Option (right to buy) | +11,389 | 11,389 | ||
| 2025-06-12 | Loxam Teri Director | Grant or award | +3,041 | 10,216 | ||
| 2025-06-12 | Loxam Teri Director | Grant or award · Stock Option (right to buy) | +15,372 | 15,372 | ||
| 2025-01-15 | Loxam Teri Director | Exercise or conversion 10b5-1 | +6,250 | $22.70 | $142K | 13,425 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −146 | $80.46 | $12K | 13,279 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −215 | $81.53 | $18K | 13,064 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −1,136 | $82.89 | $94K | 11,928 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −1,202 | $83.93 | $101K | 10,726 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −1,043 | $85.29 | $89K | 9,683 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −966 | $86.26 | $83K | 8,717 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −1,013 | $87.38 | $89K | 7,704 |
| 2025-01-15 | Loxam Teri Director | Sale 10b5-1 | −529 | $88.54 | $47K | 7,175 |
| 2025-01-15 | Loxam Teri Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,250 | 6,250 | ||
| 2024-09-17 | Loxam Teri Director | Exercise or conversion 10b5-1 | +6,250 | $22.70 | $142K | 13,425 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −241 | $114.64 | $28K | 13,184 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −1,445 | $115.32 | $167K | 11,739 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −4,308 | $116.62 | $502K | 7,431 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −256 | $117.51 | $30K | 7,175 |
| 2024-09-17 | Loxam Teri Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,250 | 12,500 |
Page 1 of 2 · 27 trades